PCOS. pregnancy complications. Prof. Bart CJM Fauser. Dept. Reproductive Medicine and Gynecology. University Medical Center, Utrecht, The Netherlands
|
|
- Aleesha Allen
- 5 years ago
- Views:
Transcription
1 PCOS pregnancy complications Prof. Bart CJM Fauser Dept. Reproductive Medicine and Gynecology University Medical Center, Utrecht, The Netherlands
2 Disclosure of interest, Fauser Professor of Reproductive Medicine Chair, WHO steering committee infertility guidelines Board member Dutch Medical Research Counsel Chief Editor Reproductive Biomedicine Online COGI chair Executive boards international organisations Consultant various pharmaceutical companies Visiting professor at different international institutions
3 PCOS, a condition requiring live long attention Reproductive disorders Metabolic disease 15 yrs 60 yrs Future health child Future health women
4 PCOS, Cross generations Fertility intervention Periconception Intervention? Pregnancy Intervention? Childhood Intervention? PCOS Pregnancy Birth Childhood NATURE NURTURE Adult Health
5 Periconceptional medicine PCOS: Genetic predisposition Environmental factors 5
6 HR 2012 Cumulative pregnancy rates resulting in singleton live birth
7 Odds ratio 95% CI No Studies Gestational diabetes Pregnancy induced hypertension Hum Reprod Upd 2006 Sample size > Preeclampsia Birth weight (WMD) NICU admission Perinatal death
8 OR gestational diabetes in PCOS HRU 2006
9 pregnancy outcomes in PCOS - summary Outcome Metaanalysis1 === Boomsma, HRU 06 Metaanalysis2 === Kjerulff, AJOG 11 Population based cohort === Roos, BMJ 11 Gest. diabetes Pre-eclampsia Preterm birth
10 189 pregnant women with PCOS Factors in the model: Relatives with type 2 DM Fasting glucose Fasting insulin AD SHBG
11 Pregnancy complications in PCOS - especially in the hyperandrogenic fenotype 188 PCOS and controls
12 Neonatal complications in PCOS children - especially in the hyperandrogenic fenotype
13 2016 Uncomplicated PCOS/Uncomplicated PCOS/GDM PCOS/pre-eclampsia F&S 2016
14 JCEM 2009
15 PCOS children (3-4 years) PCOS children Reference group Adjusted mean difference P value adjusted Anthropometry (n= 42) (n=168) (95% CI) age Blood pressure Systolic blood pressure (mmhg) 93.4 ± ± (-3.0 to 2.6) 0.89 Diastolic blood pressure (mmhg) 47.7 ± ± (-5.2 to -0.7) 0.01 Mean arterial pressure (mmhg) 62.9 ± ± (-4.3 to 0.1) 0.06 Pulse pressure (mmhg) 45.7 ± ± (0.5 to 5.0) 0.02 Arterial stiffness Pulse wave velocity aorta (m/s) 5.8 ± ± (-0.2 to 0.5) 0.49 Pulse pressure aorta (mmhg) 38.0 ± ± (-0.2 to 3.9) 0.08 Systolic blood pressure on aorta (mmhg) 85.2 ± ± (-5.3 to 1.2) 0.21 Echocardiography Left ventricle internal diameter end-diastolic (mm) (PLAX) 33.7 ± ± (0.4 to 2.5) 0.01 Z-score left ventricle internal diameter end-diastolic * a 0.4 ± ± (0.2 to 0.9) Left ventricle internal diameter end-systolic (mm) (PLAX) 22.3 ± ± (0.2 to 1.9) 0.02 Tissue doppler imaging septum systole (cm/s) 6.5 ± ± (-0.7 to -0.1) 0.01 De Wilde, Submitted
16 PCOS children (6-8 years) PCOS group Reference group Adjusted mean difference *a Anthropometry (n=32) (n=130) (95% CI) P value adjusted for age & weight Endocrinology Glucose (mmol/l) 4.7 ± ± (-0.1 to 0.4) 0.07 Insulin (miu/l) 4.4 ± ± (-2.2 to 0.8) 0.34 Cholesterol (mmol/l) 4.9 ± ± (0.3 to 1.2) Triglycerides (mmol/l) 0.7 ± ± (0.1 to 0.3) HDL-cholesterol (mmol/l) 1.5 ± ± (-0.1 to 0.2) 0.39 LDL-cholesterol (mmol/l) 3.1 ± ± (0.1 to 0.9) 0.02 CRP (mg/l) 1.6 ± ± (-3.1 to 0.8) 0.25 Carotid IMT Carotid int media thickness (µm) ± ± (6.4 to 43.0) 0.01 De Wilde, Submitted
17 Summary of Case control studies; Children of women with PCOS Design Country, no childr PCOS diagnosis Offsprin g (n) Offspring age Outcomes studied Results Kent 2008 Recabarren 2008 Infants Recabarren 2008 Childhood Sir-Petermann 2007 Prepuberty Sir-Petermann 2007 Puberty Sir-Petermann 2009 Tanner I Sir-Petermann 2009 Tanner II Sir-Petermann 2009 Tanner III Sir-Petermann 2009 Tanner IV Sir-Petermann 2009 Tanner V Legro, 2017 Case Control USA NIH 1990 :7 :10 P=17, : 11 C=16 : ± ± ± ±1.3 BMI, fasting glucose, insulin, lipids, gonadotropins, sex steroids CC Chile NIH 1990 : ( ) BMI, fasting : ( ) P=80, C=56 : ( ) : ( ) Glucose, insulin, HOMA-IR, riglycerides,ldl SHBG, adiponectin, leptin, CRP CC Chile NIH 1990 : ( ) BMI, fasting : ( ) P=75, C=49 : (101-6) : (10-17) glucose, insulin, lipids gonadotropins, sex steroids, SHBG, adiponectin CC Chile NIH 1990 : ±0.9 BMI, fasting : ±1.2 CC matched P=99, C=84 USA P=76 C=80 NIH 1990 : ±1.0 : ±0.7 : ±1.5 : ±1.0 : ±1.5 : ±1.4 : ±1.7 : ±1.1 only 4-17 yrs glucose, insulin, lipids, gonadotropins, sex steroids, SHBG Gonad and sex steroids, in urine Salivary insulin No Hyperinsulinemia in PCOS children until the later. Other reproductive abnormalities may also develop later. Sons of PCOS women exhibit higher body weight from early infancy. Insulin resistance became evident as they got older, risk factor for later onset of type 2 diabetes and cardiovascular disease. Some metabolic features of PCOS present in daughters with PCOS. Adiponectin might be an early marker. PCOS daughters have hyperinsulinemia and an increased ovarian volume before the onset of puberty and persist during pubertal development. Biochemical abnormalities of PCOS appear during late puberty. No difference
18 Compromised children outcomes
19 2012 Pregnancy Conclusions (agreement) Women with PCOS may be at increased risk for adverse pregnancy outcomes, this may be exacerbated by obesity and/or IR Health should be optimized before conception (lifestyle, diet, smoking, etc) Miscarriage rates are not increased in PCOS Pregnancy should be observed closely (GDM, hypertension) Pregnancy associated risk are greater in PCOS diagnosed by NIH criteria Babies born may have increased morbidity and mortality No evidence for decreased pregnancy complications with use of metformin before conception/during pregnancy Level of evidence B B A B B B A
20 2012 Pregnancy - Knowledge gaps Any value of periconceptional diets? Should there be increased antenatal monitoring, including earlier screening for GDM, additional Doppler studies? Long-term outcome of children born from PCOS? Long-term outcome women with PCOS who develop GDM or gestational hypertension compared to women who do not conceive
21 Take Home Messages Personal considerations PCOS is heterogeneous by definition Overall infertility prognosis in PCOS is very good Compromised pregnancy / children outcomes Influence nature vs nurture on child health uncertain Need intervention studies with proper follow-up / end-points
22 Reproductive Research Group PhD students, and collaborators Rotterdam ( ) Pache, Schoot, vsantbrink, Schipper, Imani, de Jong, vheusden Eijkemans, Mulders, Hohmann, Heijnen, Baart, de Klerk, vdgaast Blok, Laven, Macklon Utrecht (2004-) Verberg, Knauff, vdisseldorp Janse, Voorhuis, Kasius, Verhulst, Broer, Hamdin, Sterrenburg, de Wilde, Daan Broekmans, Heijnen, Eijkemans Main international collaborations; Devroey (Brussels), Bouchard (Paris), Tarlatzis (Greece), Hsueh (stanford)
Original Article Pregnancy Complications - Consequence of Polycystic Ovary Syndrome or Body Mass Index?
Chettinad Health City Medical Journal Original Article Puvithra T*, Radha Pandiyan**, Pandiyan N*** *Assistant Professor, **Senior Consultant & Associate Professor, ***Prof & HOD, Department of Andrology
More informationProblems in PCOS pregnancy
Problems in PCOS pregnancy Miscarriage Admission to NICU Cesarean Section Preeclampsia Mother Prematurity Preterm labour PIH Perinatal mortality Gestational Diabetes Problems with PCOS Pregnancy Problems
More informationMETABOLIC SYNDROME IN REPRODUCTIVE FEMALES
METABOLIC SYNDROME IN REPRODUCTIVE FEMALES John J. Orris, D.O., M.B.A Division Head, Reproductive Endocrinology & Infertility, Main Line Health System Associate Professor, Drexel University College of
More informationPregnancy outcome in women with polycystic ovary syndrome
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Nivedhitha VS et al. Int J Reprod Contracept Obstet Gynecol. 2015 Aug;4(4):1169-1175 www.ijrcog.org pissn 2320-1770 eissn
More informationDiabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome
Diabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome John E. Nestler, M.D. William Branch Porter Professor of Medicine Chair, Department of Internal Medicine Virginia Commonwealth University
More informationRotterdam Criteria 9/30/2017. A Changing Paradigm in PCOS. Polycystic Ovary Syndrome - Is the Cardiometabolic Risk Increased After Menopause?
Disclosure Polycystic Ovary Syndrome - Is the Cardiometabolic Risk Increased After Menopause? Fractyl laboratories, Inc Anuja Dokras, MD., Ph.D. Professor of Obstetrics and Gynecology Director PENN PCOS
More informationRISK OF EARLY & LATE OBSTETRIC COMPLICATIONS IN WOMEN WITH IVF- CONCEIVED PREGNANCIES AND POLYCYSTIC OVARY SYNDROME (PCOS)
RISK OF EARLY & LATE OBSTETRIC COMPLICATIONS IN WOMEN WITH IVF- CONCEIVED PREGNANCIES AND POLYCYSTIC OVARY SYNDROME (PCOS) N. A. Bagegni, BS 1, J Blaine, BS 1, B J VanVoorhis, MD 1, A Dokras, MD.PhD 2
More informationPrevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai
Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai Principal Investigator Co- Investigators Consultant Collaborating Hospital Dr. Beena Joshi Dr. Srabani Mukherji
More informationPregnancy complications and glucose intolerance in women with polycystic ovary syndrome
Endocrine Journal 2015, 62 (11), 1017-1023 Original Pregnancy complications and glucose intolerance in women with polycystic ovary syndrome Mari Sawada, Hisashi Masuyama, Kei Hayata, Yasuhiko Kamada, Keiichiro
More informationEndothelial function is impaired in women who had pre-eclampsia
Endothelial function is impaired in women who had pre-eclampsia Christian Delles, Catriona E Brown, Joanne Flynn, David M Carty Institute of Cardiovascular and Medical Sciences University of Glasgow United
More informationTiming and tempo of first year growth in relation to cardiovascular and metabolic risk profile in early adulthood
Note: for non-commercial purposes only Timing and tempo of first year growth in relation to cardiovascular and metabolic risk profile in early adulthood Anita Hokken-Koelega Professor of Pediatric Endocrinology
More informationThe Impact of Insulin Resistance on Long-Term Health in PCOS
Saturday, April 16 th, 2016 PCOS Challenge & Thomas Jefferson University PCOS Awareness Symposium Philadelphia The Impact of Insulin Resistance on Long-Term Health in PCOS Katherine Sherif, MD Professor
More informationThe New GDM Screening Guidelines. Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program
The New GDM Screening Guidelines Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program Disclosures Current participant (RCH site) for MiTy study Metformin in women
More informationThoughts on PCOS Female Androgenization Syndrome FAS
Thoughts on PCOS Female Androgenization Syndrome FAS Stan Korenman, M.D. Distinguished Professor of Medicine-Endocrinology and Associate Dean - Ethics David Geffen School of Medicine at UCLA Conflicts
More informationScreening and Diagnosis of Diabetes Mellitus in Taiwan
Screening and Diagnosis of Diabetes Mellitus in Taiwan Hung-Yuan Li, MD, MMSc, PhD Attending Physician, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan Associate Professor,
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More informationPCOS & Diet Therapy. Dr. Ladan Giahi Immunonutritionist Avicenna Research Institute October 2015
PCOS & Diet Therapy Dr. Ladan Giahi Immunonutritionist Avicenna Research Institute October 2015 Questions to be discussed: 1) Why dietary modification is considered as first line of treatment? 2) What
More informationCOMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA)
COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA) Prof. Hayfaa Wahabi, King Saud University, Riyadh Saudi Arabia Hayfaa
More informationInfluence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser
Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte
More informationCARDIOVASCULAR EVENTS IN POLYCYSTIC OVARY SYNDROME
CARDIOVASCULAR EVENTS IN POLYCYSTIC OVARY SYNDROME Enrico Carmina Executive Director & CEO of Androgen Excess & PCOS Society Professor of Endocrinology Department of Health Sciences and Mother and Child
More informationObstetric complications and management in women with polycystic ovary syndrome
Obstetric complications and management in women with polycystic ovary syndrome M Tamer MUNGAN, MD., Prof Obstetrics and Gynecologıst -Perinalogy tdmungan@gmail.com F E R T I L I T Y SUBFERTILİTY INFERTILITY
More informationGestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014
Gestational Diabetes: Long Term Metabolic Consequences Gladys (Sandy) Ramos, MD Associate Clinical Professor Maternal Fetal Medicine Outline Population rates of obesity and T2DM Obesity and metabolic syndrome
More informationInternational Multispecialty Journal of Health (IMJH) ISSN: [ ] [Vol-2, Issue-11, November- 2016]
Maternal polycystic ovary syndrome (PCOS) and Antenatal (ANC) Complications: A Case Control Study Dr. Maincy Devadiya 1, Dr. Anubhav Jain 2, Dr. Sushma P. Sinha 3, Dr. Anita G. Kaul 4 and Dr. Suman Meena
More informationReproductive outcome in women with body weight disturbances
Reproductive outcome in women with body weight disturbances Zeev Shoham M.D. Dep. Of OB/GYN Kaplan Hospital, Rehovot, Israel Weight Status BMI (kg/m 2 ) Underweight
More informationPolycystic Ovarian Syndrome. Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology
Polycystic Ovarian Syndrome Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology Outline Definition Symptoms Causal factors Diagnosis Complications Treatment Why are we talking about
More informationIS PCOS ASSOCIATED WITH A HIGHER PREGNANCY LOSS? NO BY DR SHEELA V.MANE
IS PCOS ASSOCIATED WITH A HIGHER PREGNANCY LOSS? NO BY DR SHEELA V.MANE CURRICULUM VITAE Name Qualifications : Prof. Sheela V. Mane : MBBS, M.D, FICOG, FICMCH Contribution to FOGSI: Chairperson Safe Motherhood
More informationPaul Hofman. Professor. Paediatrician Endocrinologist Liggins Institute, The University of Auckland, Starship Children Hospital, Auckland
Professor Paul Hofman Paediatrician Endocrinologist Liggins Institute, The University of Auckland, Starship Children Hospital, Auckland 9:25-9:50 Endocrine and Metabolic Consequences of Being Born Preterm
More informationCREATING A PCOS TREATMENT PLAN. Ricardo Azziz, M.D., M.P.H., M.B.A. Georgia Regents University
CREATING A PCOS TREATMENT PLAN Ricardo Azziz, M.D., M.P.H., M.B.A. Georgia Regents University PCOS: CREATING A TREATMENT PLAN Good treatment plans are based on sound and complete evaluations History of
More informationValidation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome Madelon van Wely, Ph.D., a Bart C. J. M. Fauser, M.D., Ph.D., b Joop S. E. Laven,
More informationPsychological impact of Polycystic Ovary Syndrome (PCOS)
Psychological impact of Polycystic Ovary Syndrome (PCOS) Dr Mandy Deeks PhD Psychologist Former Deputy CEO & Head of Translation, Education & Communication Unit Today: 5 things to ponder 1. PCOS is complex
More informationPregnancy complications in women with polycystic ovary syndrome
Human Reproduction Update, Vol.21, No.5 pp. 575 592, 2015 Advanced Access publication on June 27, 2015 doi:10.1093/humupd/dmv029 Pregnancy complications in women with polycystic ovary syndrome Stefano
More informationPregnancy outcomes in Korean women with diabetes
Pregnancy outcomes in Korean women with diabetes Sung-Hoon Kim Department of Medicine, Cheil General Hospital & Women s Healthcare Center, Dankook University College of Medicine, Seoul, Korea Conflict
More information2/13/2018. Update on Gestational Diabetes. Disclosure. Objectives. I have no financial conflicts of interest.
Update on Gestational Diabetes Lorie M. Harper, MD, MSCI Department of Obstetrics & Gynecology Division of Maternal-Fetal Medicine 2/18/2018 Disclosure I have no financial conflicts of interest. Objectives
More informationGestational Diabetes. Gestational Diabetes:
Gestational Diabetes Detection and Management Steven Gabbe, MD The Ohio State University Medical Center Gestational Diabetes: Detection and Management Learning Objectives: At the conclusion of this presentation,
More informationOptimizing Postpartum Maternal Health to Prevent Chronic Diseases
Optimizing Postpartum Maternal Health to Prevent Chronic Diseases Amy Loden, MD, FACP, NCMP Disclosures Research: None Financial: none applicable to this presentation PRIUM QEssentials Market Research
More informationPolycystic Ovary Disease: A Common Endocrine Disorder in Women
Polycystic Ovary Disease: A Common Endocrine Disorder in Women Paul Kaplan, M.D. Clinical Professor of Reproductive Endocrinology - OHSU Courtesy Senior Research Associate, Human Physiology University
More informationS. AMH in PCOS Research Insights beyond a Diagnostic Marker
S. AMH in PCOS Research Insights beyond a Diagnostic Marker Dr. Anushree D. Patil, MD. DGO Scientist - D National Institute for Research in Reproductive Health (Indian Council of Medical Research) (Dr.
More informationMetabolic changes in menopausal transition
Metabolic changes in menopausal transition Terhi T. Piltonen M.D., Associate Professor Consultant, Clinical Researcher for the Finnish Medical Foundation Department of Obstetrics and Gynecology PEDEGO
More informationReproductive Health in Non Alcoolic Fatty Liver Disease (NAFLD)
Reproductive Health in Non Alcoolic Fatty Liver Disease (NAFLD) Pr Sophie Christin-Maitre Reproductive Endocrine Unit, Hôpital Saint-Antoine, AP-HP Université Pierre et Marie Curie INSERM U933 Paris, France
More informationOutline. Diagnos(c Criteria and PCOS features Diagnos(c Criteria by age Reproduc(ve Care for the woman with PCOS, a focus on fer(lity and pregnancy.
Across the Lifespan: PCOS and Reproduc
More informationPolycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018
Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018 Learning Objectives At the conclusion of this lecture, learners should: 1) Know the various diagnostic
More information2018 Standard of Medical Care Diabetes and Pregnancy
2018 Standard of Medical Care Diabetes and Pregnancy 2018 Standard of Medical Care Diabetes and Pregnancy Marjorie Cypress does not have any relevant financial relationships with any commercial interests
More informationMetabolic Syndrome Is A Key Determinant Of Coronary Microvascular Function In Patients With Stable Coronary Disease Undergoing PCI
Metabolic Syndrome Is A Key Determinant Of Coronary Microvascular Function In Patients With Stable Coronary Disease Undergoing PCI Narbeh Melikian*, Ajay M Shah*, Martyn R Thomas, Roy Sherwood, Mark T
More informationPREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS
PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS Mehmet Emre Atabek,MD,PhD Necmettin Erbakan University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology and
More informationThe optimal nutritional balance needed for preventing metabolic syndrome while achieving optimal development for preterm infants
Pediatric Endocrinology In Premature Infants The optimal nutritional balance needed for preventing metabolic syndrome while achieving optimal development for preterm infants Dr. Iris Morag Prof. Orit Hamiel
More informationMETABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN MORPHOLOGY
Vuk Vrhovac University Clinic Dugi dol 4a, HR-10000 Zagreb, Croatia Original Research Article Received: February 18, 2010 Accepted: March 3, 2010 METABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN
More informationJohn J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam
Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention
More informationRichard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA
What have we learned from Multi-Clinical Trials in PCOS: Focus on Infertility Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA Disclosures Consultant: Euroscreen,
More informationPolycystic ovary syndrome in young women - new ideas
Polycystic ovary syndrome in young women - new ideas Disclosures Minor shareholder IVF clinic Grant support MSD, Merck and Ferring Grant support NHMRC Perspective is everything in PCOS Peacock s 2013 Polycystic
More informationAchieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center
Achieving Pregnancy: Obesity and Infertility Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center Disclosures Speakers Bureau EMD Serono Board of Directors Nurse
More informationUpdate on PCOS Research. Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA
Update on PCOS Research Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA Conflicts Consultant: Euroscreen, AstraZeneca, Ferring, Clarus, Kindex, Takeda Funding:
More informationVitamin D supplementation of professionally active adults
Vitamin D supplementation of professionally active adults VITAMIN D MINIMUM, MAXIMUM, OPTIMUM FRIDAY, SEPTEMBER 22 ND 2017 Samantha Kimball, PhD, MLT Research Director Pure North S Energy Foundation The
More information3. Metformin therapy for PCOS
1. Introduction The key clinical features of polycystic ovary syndrome (PCOS) are hyperandrogenism (hirsutism, acne, alopecia) and menstrual irregularity with associated anovulatory infertility. 1 The
More informationVishwanath Pattan Endocrinology Wyoming Medical Center
Vishwanath Pattan Endocrinology Wyoming Medical Center Disclosure Holdings in Tandem Non for this Training Introduction In the United States, 5 to 6 percent of pregnancies almost 250,000 women are affected
More informationA mild strategy in IVF results in favourable outcomes in terms of term live birth, cost and patient discomfort
Chapter 6 A mild strategy in IVF results in favourable outcomes in terms of term live birth, cost and patient discomfort Heijnen E.M., Eijkemans M.J., De Klerk C., Polinder S., Beckers N.G., Klinkert E.R.,
More informationOn the path to less intrusive IVF
23rd Annual Meeting of the European Society of Human Reproduction and Embryology Lyon, France July 1 4, 2007 Organon Sponsored Symposium Monday, July 2, 2007, 11.45 AM 1.00 PM L Amphithéâtre, Palais des
More informationPolycystic ovarian syndrome Can lifestyle modifications help?? Dr Saloni Assistant Professor, Deptt of OBG BPSGMC for Women, Khanpur Kalan
Polycystic ovarian syndrome Can lifestyle modifications help?? Dr Saloni Assistant Professor, Deptt of OBG BPSGMC for Women, Khanpur Kalan Life-long condition Hirsutism Menstrual irregularities? Pronounced
More informationPolycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks
Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks Kate D. Schoyer, M.D. May 6, 2016 Objectives To review how to make the diagnosis of Polycystic Ovarian Syndrome (PCOS)
More informationClinical Study Risks for Gestational Diabetes Mellitus and Pregnancy-Induced Hypertension Are Increased in Polycystic Ovary Syndrome
Hindawi Publishing Corporation BioMed Research International Volume 2013, Article ID 182582, 6 pages http://dx.doi.org/10.1155/2013/182582 Clinical Study Risks for Gestational Diabetes Mellitus and Pregnancy-Induced
More informationEpidemiology and Prevention
Epidemiology and Prevention Associations of Pregnancy Complications With Calculated Cardiovascular Disease Risk and Cardiovascular Risk Factors in Middle Age The Avon Longitudinal Study of Parents and
More informationDr.Shobha N Gudi. Prof. and HOD. Dept of OBG. St. Philomenas Hospital, Dr Malathi Manipal hospital, Excel Care, Sagar Chandramma Hospitals, Bangalore.
Dr.Shobha N Gudi MD, DNB, FICOG, CIMP Prof. and HOD. Dept of OBG. St. Philomenas Hospital, Dr Malathi Manipal hospital, Excel Care, Sagar Chandramma Hospitals, Bangalore. President elect BSOG (Bengaluru
More informationDiabetic Medicine. Myo-inositol may prevent gestational diabetes in PCOS women. Preliminary data.
Myo-inositol may prevent gestational diabetes in PCOS women. Preliminary data. Journal: Diabetic Medicine Manuscript ID: DME--00 Manuscript Type: Short Report Date Submitted by the Author: -May- Complete
More informationAEPCOS NewSLET TER A N D R O G E N E X C E S S & P C O S S O C I E T Y. V o l u m e 2, I s s u e 12 D E C E M B E R 3 1,
AEPCOS NewSLET TER A N D R O G E N E X C E S S & P C O S S O C I E T Y D E C E M B E R 2 0 1 4 n e w s l e t t e r S M O K I N G I N W O M E N W I T H P C O S This issue newsletter reports the final program
More informationPregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes
Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes Stefano Palomba, M.D., a Angela Falbo, M.D., a Tiziana Russo, M.D.,
More informationPolycystic Ovary Syndrome (PCOS):
Polycystic Ovary Syndrome (PCOS): Current diagnosis and treatment Anatte E. Karmon, MD Disclosures- Anatte Karmon, MD No financial relationships to disclose 2 Objectives At the end of this presentation,
More informationMetabolomic profiles of childhood obesity
Note: for non-commercial purposes only Metabolomic profiles of childhood obesity Wei Perng, Matthew W. Gillman, Abby F. Fleisch, Ryan D. Michalek, Steven Watkins, Elvira Isganaitis, Mary-Elizabeth Patti,
More informationProven and Proposed Cardiovascular Benefits of Soyfoods
Proven and Proposed Cardiovascular Benefits of Soyfoods Mark Messina, PhD, MS Soy Nutrition Institute Loma Linda University Nutrition Matters, Inc. markjohnmessina@gmail.com Alpro Foundation 20 years symposium
More informationThe Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk
The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine
More informationAdolescent renal and cardiovascular disease protection in type 1 diabetes AdDIT Study
Keystone, Colorado, July 2013 Practical Ways to Achieve Targets in Diabetes Care Adolescent renal and cardiovascular disease protection in type 1 diabetes AdDIT Study Professor David Dunger Department
More informationOn the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome an epi-analysis
A C TA Obstetricia et Gynecologica AOGS SHORT RESEARCH REPORT On the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome an epi-analysis ESZTER VANKY 1,2, FRANCIS
More informationCounseling and Long-term Follow up After Gestational Disorders
Counseling and Long-term Follow up After Gestational Disorders Tanya Melnik, MD Assistant Professor, University of Minnesota Sarina Martini, MD Ob/Gyn Resident, PGY4 University of Minnesota Counseling
More information(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects
Table 1. Distribution of baseline characteristics across tertiles of OPG adjusted for age and sex (n=6279). Continuous variables are reported as mean with 95% confidence interval and categorical values
More informationComplications of Pregnancy and Lifetime Risk to Health. Brian McCulloch MD Advocate Lutheran General Hospital September 26, 2015
Complications of Pregnancy and Lifetime Risk to Health Brian McCulloch MD Advocate Lutheran General Hospital September 26, 2015 Pregnancy as a window to future health In 2005 the CDC stated that almost
More informationWhy Screen at 23? What can YOU do?
Why Screen at 23? Every 1 in 2 Asian American adults has diabetes or prediabetes. More than half of Asian Americans did not know they have type 2 diabetes or prediabetes. Asian Americans can develop diabetes
More informationDiabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology
Diabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology Disclosures In compliance with the accrediting board policies, the American Diabetes Association requires the
More informationPolycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks. Kate D. Schoyer, M.D. May 6, 2016
Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks Kate D. Schoyer, M.D. May 6, 2016 Objectives To review how to make the diagnosis of Polycystic Ovarian Syndrome (PCOS)
More informationObesity and Fertility in Women: Can we and should we treat obesity prior to conception?
Obesity and Fertility in Women: Can we and should we treat obesity prior to conception? Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA Obesity and Fertility in
More informationEarly determinants of cardiovascular, metabolic and reproductive health --- EDCaR.
Early determinants of cardiovascular, metabolic and reproductive health --- EDCaR. Harri Niinikoski MD, PhD, Pediatric endocrinologist Professor of Nutrition in Medicine University of Turku/Physiology
More informationOverview. In Vitro Fertilization: a Success Story
Does IVF cause adverse perinatal outcomes? Paolo Rinaudo *, MD PhD Rebecca A. Jackson %, MD Departments of Ob/Gyn & *Center for Reproductive Sciences & % Epi/Biostats University of California, San Francisco
More informationIntroduction. Original Article
Original Article Cardiovascular and Metabolic Health of 74 Children From Women Previously Diagnosed With Polycystic Ovary Syndrome in Comparison With a Population-Based Reference Cohort Reproductive Sciences
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More informationDoes (rapid) early weight gain cause adult disease and obesity? Ines M. Anchondo DrPH, RD, CSP
Does (rapid) early weight gain cause adult disease and obesity? Ines M. Anchondo DrPH, RD, CSP Annotated Reference List Adair, L. S., et al. (2009). "Size at birth, weight gain in infancy and childhood,
More informationLessons from conducting research in an American Indian community: The Pima Indians of Arizona
Lessons from conducting research in an American Indian community: The Pima Indians of Arizona Peter H. Bennett, M.B., F.R.C.P. Scientist Emeritus National Institute of Diabetes and Digestive and Kidney
More informationNew PCOS guidelines: What s relevant to general practice
New PCOS guidelines: What s relevant to general practice Dr Michael Costello Fertility Specialist IVF Australia UNSW Royal Hospital for Women Sydney How do we know if something is new? Louvre Museum, Paris
More informationCARDIOVASCULAR RISK FACTORS. Harpal S Randeva. Warwick Medical School University of Warwick, UK
NORDIC FEDERATION OF SOCIETIES OF OBSTETRICS AND GYNAECOLOGY November, 2010 POLYCYSTIC OVARY SYNDROME THROUGH LIFE CARDIOVASCULAR RISK FACTORS Harpal S Randeva Warwick Medical School University of Warwick,
More informationPCOS Awareness Symposium Atlanta September 24 th, Preventing Diabetes & Cardiovascular Disease in PCOS
PCOS Awareness Symposium Atlanta September 24 th, 2016 Preventing Diabetes & Cardiovascular Disease in PCOS Katherine Sherif, MD Professor & Vice Chair, Department of Medicine Director, Jefferson Women
More informationManagement of Pregestational and Gestational Diabetes Mellitus
Background and Prevalence Management of Pregestational and Gestational Diabetes Mellitus Pregestational Diabetes - 8 million women in the US are affected, complicating 1% of all pregnancies. Type II is
More informationObjectives. Diabetes and Obesity in Pregnancy. In Diabetes. Diabetes in Pregnancy
Objectives Diabetes and Obesity in Pregnancy. Health Impact for the mother and child Bresta Miranda, MD Assistant Professor of Clinical Medicine University of Miami, Miller School of Medicine Review physiologic
More informationAdverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control study
ORIGINAL ARTICLE pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 2011;38(2):103-108 Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome:
More informationLaboratory analysis of the obese child recommendations and discussion. MacKenzi Hillard May 4, 2011
Laboratory analysis of the obese child recommendations and discussion MacKenzi Hillard May 4, 2011 aka: What to do with Fasting Labs The Obesity Epidemic The prevalence of obesity in adolescents has tripled
More informationWhat is PCOS? PCOS THE CONQUER PCOS E-BOOK. You'll be amazed when you read this...
PCOS What is PCOS? You'll be amazed when you read this... What is PCOS?. Who is at risk? How to get tested? What are the complications. Is there a cure? What are the right ways to eat? What lifestyle changes
More informationSupplemental Table 1. Study design and participant characteristics.
Supplemental Table 1. Study design and participant characteristics. Study ID Study Design; Total No. of Participants Mean age at Parity Participant Selection Criteria Country; Year (PE/no PE) Index Pregnancy
More information10/29/2011. Metabolic, Obstetric, and Gynecological Consequences of Bariatric Surgery. Case Presentation: Rachelle. Jonathan Carter, MD
Metabolic, Obstetric, and Gynecological Consequences of Bariatric Surgery 2,000 B.C. 2,000 A.D. Case Presentation: Rachelle 35 year-old woman with morbid obesity. 5 1 236 lbs BMI 44.5 PMHx: mild depression
More informationGestational Diabetes Mellitus Dr. Fawaz Amin Saad
Gestational Diabetes Mellitus Dr. Fawaz Amin Saad Senior Consultant OB/GYN, Al-Hayat Medical Center, Doha, Qatar DISCLOSURE OF CONFLICT OF INTEREST I am a full-time Employee at Al-Hayat Medical Center.
More informationThe Ever-Changing Approaches to Diabetes in Pregnancy
The Ever-Changing Approaches to Diabetes in Pregnancy Kirsten E. Salmeen, MD Assistant Professor Obstetrics, Gynecology & Reproductive Sciences Maternal-Fetal Medicine I have nothing to disclose. Approaches
More informationSocioeconomic inequalities in lipid and glucose metabolism in early childhood
10 Socioeconomic inequalities in lipid and glucose metabolism in early childhood Gerrit van den Berg, Manon van Eijsden, Francisca Galindo-Garre, Tanja G.M. Vrijkotte, Reinoud J.B.J. Gemke BMC Public Health
More informationDiagnosis and Management of Polycystic Ovary Syndrome During Adolescence: Questions and Controversies
Diagnosis and Management of Polycystic Ovary Syndrome During Adolescence: Questions and Controversies 2017 Illinois-AACE 2017 Annual Meeting October 14, 2017 Learning Objectives 1) Understand the challenges
More informationMetabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More information12/27/2013. Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND
Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND 7% of all women 18-45 Obesity 1/3 of all US women Incidence of PCOS is increasing with increase obesity Obesity Irregular
More information